Treatment of Arthritis With Syk Kinase Inhibition (TASKI-1)

Clinical trial NCT00326339 · COMPLETED

Trial details

NCT number: NCT00326339
Sponsor: Rigel Pharmaceuticals
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Rheumatoid Arthritis

Start date: 2006-08-01
Primary completion: 2007-10-01
Enrollment: 189

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.